Daniil Gataulin
Stock Analyst at Chardan Capital
(4.79)
# 114
Out of 5,115 analysts
119
Total ratings
62.39%
Success rate
44.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintains: Buy | $52 | $11.16 | +365.95% | 15 | Jan 29, 2026 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.45 | +382.76% | 15 | Jan 20, 2026 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 → $1 | $0.44 | +127.43% | 11 | Jan 5, 2026 | |
| ANNX Annexon | Initiates: Buy | $16 | $6.24 | +156.41% | 1 | Dec 23, 2025 | |
| KLRS Kalaris Therapeutics | Initiates: Buy | $19 | $8.88 | +113.96% | 1 | Dec 23, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $9.14 | +129.76% | 4 | Dec 9, 2025 | |
| QURE uniQure | Maintains: Buy | $53 | $22.72 | +133.27% | 11 | Dec 4, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $29.27 | +108.40% | 7 | Nov 17, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $22.77 | -38.52% | 4 | Nov 17, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $5.68 | +76.06% | 3 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 | $7.61 | +359.92% | 7 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $2.31 | +289.61% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 | $28.45 | +79.26% | 9 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $5.15 | +191.26% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.09 | +266.97% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $13.52 | +99.70% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.60 | +36,323.84% | 1 | Mar 7, 2024 |
REGENXBIO
Jan 29, 2026
Maintains: Buy
Price Target: $52
Current: $11.16
Upside: +365.95%
Ocugen
Jan 20, 2026
Maintains: Buy
Price Target: $7
Current: $1.45
Upside: +382.76%
Outlook Therapeutics
Jan 5, 2026
Maintains: Neutral
Price Target: $3 → $1
Current: $0.44
Upside: +127.43%
Annexon
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $6.24
Upside: +156.41%
Kalaris Therapeutics
Dec 23, 2025
Initiates: Buy
Price Target: $19
Current: $8.88
Upside: +113.96%
Ocular Therapeutix
Dec 9, 2025
Maintains: Buy
Price Target: $21
Current: $9.14
Upside: +129.76%
uniQure
Dec 4, 2025
Maintains: Buy
Price Target: $53
Current: $22.72
Upside: +133.27%
Forte Biosciences
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $29.27
Upside: +108.40%
Kodiak Sciences
Nov 17, 2025
Maintains: Neutral
Price Target: $14
Current: $22.77
Upside: -38.52%
Zura Bio
Nov 14, 2025
Maintains: Buy
Price Target: $10
Current: $5.68
Upside: +76.06%
Nov 14, 2025
Maintains: Buy
Price Target: $35
Current: $7.61
Upside: +359.92%
Nov 13, 2025
Maintains: Buy
Price Target: $9
Current: $2.31
Upside: +289.61%
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $28.45
Upside: +79.26%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $5.15
Upside: +191.26%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.09
Upside: +266.97%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $13.52
Upside: +99.70%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.60
Upside: +36,323.84%